Shanghai Henlius Biotech’s Collaboration and License Agreement with Palleon Pharmaceuticals

Fangda advised Shanghai Henlius Biotech, Inc. on the deal.Shanghai Henlius Biotech, Inc. (“Henlius”, 2696.HK) secured a collaboration and license agreement with Palleon Pharmaceuticals (“Palleon”) to develop…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Maha Kanaan

Author: Maha Kanaan

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here